|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.84 USD | +0.82% |
|
-5.14% | +212.07% |
| 07-29 | Corcept Therapeutics Incorporated, Q2 2026 Earnings Call, Jul 29, 2026 | |
| 07-29 | (CORT) Corcept Therapeutics Expects Full Year 2026 Revenue Range $1.1B - $1.2B, vs. FactSet Est of $999.5M | MT |
| Market Cap | 11.67B 10.13B 9.48B 8.67B 16.38B 1,112B 16.59B 111B 43.54B 555B 43.81B 42.86B 1,849B | P/E 2026 * |
53.3x | P/E 2027 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11.46B 9.94B 9.31B 8.52B 16.08B 1,091B 16.29B 109B 42.74B 545B 43.01B 42.08B 1,815B | EV / Sales 2026 * |
10.3x | EV / Sales 2027 * | 6.87x |
| Free-Float |
66.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | +0.84% | ||
| 1 week | -5.14% | ||
| Current month | -5.14% | ||
| 1 month | +15.48% | ||
| 3 months | +112.73% | ||
| 6 months | +162.89% | ||
| Current year | +212.07% |
| 1 week | 107.32 |  | 115 |
| 1 month | 84.88 | | 122.21 |
| Current year | 28.66 | | 122.21 |
| 1 year | 28.66 | | 122.21 |
| 3 years | 20.84 | | 122.21 |
| 5 years | 15.82 | | 122.21 |
| 10 years | 5.24 | | 122.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Sell | Chief Technology Officer | -1,540 | 0.0014% | ||
| 8/3/26 | Fiscal year | Executive/Senior Manager | 60,915 | 0.0567% | ||
| 7/30/26 | Fiscal year | Chief Financial Officer | 240,000 | 0.2236% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.82% | -5.14% | +51.93% | +259.25% | 11.67B | |
| -0.26% | +3.60% | +85.73% | +162.12% | 1,062B | |
| +0.32% | +0.42% | +50.07% | +48.71% | 619B | |
| +0.62% | -2.35% | +23.23% | +63.01% | 431B | |
| +1.44% | +4.69% | +48.62% | +39.78% | 358B | |
| +0.91% | -0.13% | +35.88% | +40.72% | 293B | |
| +0.56% | -5.53% | +8.99% | +9.63% | 247B | |
| +0.59% | +5.64% | +42.92% | +60.87% | 219B | |
| +4.41% | -0.03% | -0.79% | -43.85% | 200B | |
| +2.23% | +2.28% | +20.77% | +65.10% | 162B | |
| Average | +1.18% | -2.59% | +36.73% | +70.53% | 360.4B | |
| Weighted average by Cap. | +0.72% | -0.85% | +48.68% | +76.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.11B 964M 902M 825M 1.56B 106B 1.58B 10.56B 4.14B 52.85B 4.17B 4.08B 176B | 1.63B 1.41B 1.32B 1.21B 2.29B 155B 2.32B 15.5B 6.08B 77.58B 6.12B 5.99B 258B |
| Net income | 242M 210M 197M 180M 340M 23.06B 344M 2.3B 903M 11.52B 909M 889M 38.34B | 645M 560M 524M 480M 905M 61.46B 917M 6.13B 2.41B 30.71B 2.42B 2.37B 102B |
| Net Debt | -213M -185M -173M -159M -299M -20.33B -303M -2.03B -796M -10.16B -801M -784M -33.8B | -474M -412M -385M -352M -665M -45.17B -674M -4.51B -1.77B -22.57B -1.78B -1.74B -75.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$108.60 | +0.60% | 64,705 |
| 26-08-06 | US$107.95 | -2.48% | 761,834 |
| 26-08-05 | US$110.69 | +0.81% | 846,859 |
| 26-08-04 | US$109.80 | -2.66% | 1,266,014 |
| 26-08-03 | US$112.80 | -1.48% | 1,688,643 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
